Detalles de la búsqueda
1.
Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection.
J Antimicrob Chemother
; 79(4): 875-882, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38394463
2.
Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment.
Antimicrob Agents Chemother
; 67(11): e0050523, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37823647
3.
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections.
Antimicrob Agents Chemother
; 67(10): e0053523, 2023 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768311
4.
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
Clin Infect Dis
; 73(7): e1507-e1517, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897367
5.
Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32179519
6.
Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016.
Antimicrob Agents Chemother
; 63(1)2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373807
7.
A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges.
Expert Rev Respir Med
; 17(11): 973-988, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37962332
8.
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720.
Expert Rev Anti Infect Ther
; 21(11): 1177-1187, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37862563
9.
Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020.
Diagn Microbiol Infect Dis
; 103(3): 115713, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598410
10.
A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.
Pediatr Infect Dis J
; 40(6): e222-e229, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33480665
11.
Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017).
Diagn Microbiol Infect Dis
; 94(3): 304-313, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808530
12.
Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.
Pediatr Infect Dis J
; 24(4): 293-300, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15818287
13.
Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
Pediatr Infect Dis J
; 24(4): 301-8, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15818288
14.
Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.
Pediatr Infect Dis J
; 22(11): 943-9, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14614364
15.
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.
Clin Ther
; 24(12): 2088-104, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12581547
Resultados
1 -
15
de 15
1
Próxima >
>>